Comparison of lactate/albumin ratio to lactate and lactate clearance for predicting outcomes in patients with septic shock admitted to intensive care unit: an observational study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
29 07 2022
Historique:
received: 01 12 2021
accepted: 13 06 2022
entrez: 29 7 2022
pubmed: 30 7 2022
medline: 3 8 2022
Statut: epublish

Résumé

The aim of this study was to evaluate the prognostic value of the Lactate to Albumin (L/A) ratio compared to that of lactate and lactate clearance in predicting outcomes in patients with septic shock. This was a multi-center observational study of adult patients with septic shock, who admitted to intensive care units (ICUs) at Shohada and Imam Reza Hospitals, Tabriz, Iran, between Sept 2018 and Jan 2021. The area under the curve (AUC) of receiver operating characteristic (ROC) curve and multivariate logistic regression analyses were used to explore associations of the L/A ratio, lactate and lactate clearance on the primary (mortality) and secondary outcomes [ICU length of stay (LOS), duration of mechanical ventilation (MV), need of renal replacement therapy (RRT) and duration of using vasopressors] at baseline, 6 h and 24 h of septic shock recognition. Best performing predictive value for mortality were related to lactate clearance at 24 h, L/A ratio at 6 h and lactate levels at 24 h with (AUC 0.963, 95% CI 0.918-0.987, P < 0.001), (AUC 0.917, 95% CI 0.861-0.956, P < 0.001), and (AUC 0.904, 95% CI 0.845-0.946, P < 0.001), respectively. Generally, the lactate clearance at 24 h had better prognostic performance for mortality and duration of using vasopressor. However, the L/A ratio had better prognostic performance than serum lactate and lactate clearance for RRT, ICU LOS and MV duration.

Identifiants

pubmed: 35906231
doi: 10.1038/s41598-022-14764-z
pii: 10.1038/s41598-022-14764-z
pmc: PMC9338032
doi:

Substances chimiques

Albumins 0
Lactic Acid 33X04XA5AT

Types de publication

Comparative Study Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13047

Informations de copyright

© 2022. The Author(s).

Références

Int J Mol Sci. 2017 Sep 02;18(9):
pubmed: 28869492
J Crit Care. 2010 Jun;25(2):276-81
pubmed: 20149587
PLoS One. 2016 Sep 09;11(9):e0160466
pubmed: 27611431
Shock. 2013 Nov;40(5):358-65
pubmed: 24088989
J Crit Care. 2015 Apr;30(2):271-5
pubmed: 25537574
Pharmacotherapy. 2019 Sep;39(9):946-963
pubmed: 31361914
Front Med (Lausanne). 2020 Sep 22;7:550182
pubmed: 33072780
Int J Gen Med. 2021 Dec 30;14:10511-10525
pubmed: 35002307
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
J Intensive Care. 2021 Oct 18;9(1):63
pubmed: 34663479
Ann Intern Med. 1986 Jul;105(1):16-20
pubmed: 3717806
Crit Care Med. 2004 Aug;32(8):1637-42
pubmed: 15286537
Intensive Care Med. 1999 Jul;25(7):686-96
pubmed: 10470572
N Engl J Med. 2014 May 1;370(18):1683-93
pubmed: 24635773
Daru. 2010;18(3):155-62
pubmed: 22615611
J Trauma Acute Care Surg. 2013 Apr;74(4):999-1004
pubmed: 23511137
JAMA. 2010 Feb 24;303(8):739-46
pubmed: 20179283
Shock. 2016 Jan;45(1):4-9
pubmed: 26674449
Medicine (Baltimore). 2007 Jul;86(4):225-232
pubmed: 17632264
Clin Exp Emerg Med. 2015 Dec 28;2(4):197-202
pubmed: 27752598
Clin Endocrinol (Oxf). 2011 Feb;74(2):191-6
pubmed: 21039727
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Ann Intensive Care. 2013 Feb 12;3(1):3
pubmed: 23398782
Scand J Clin Lab Invest. 2021 May;81(3):225-229
pubmed: 33745405
Crit Care. 2014 May 12;18(3):R97
pubmed: 24887489
Radiology. 1983 Sep;148(3):839-43
pubmed: 6878708
Ann Intensive Care. 2013 May 10;3(1):12
pubmed: 23663301
Sci Rep. 2021 Mar 18;11(1):6313
pubmed: 33737668
Intensive Care Med. 2018 Jun;44(6):925-928
pubmed: 29675566
Clin Microbiol Rev. 2012 Oct;25(4):609-34
pubmed: 23034322
Crit Care Med. 2010 Apr;38(4):1045-53
pubmed: 20048677
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
Shock. 2018 Nov;50(5):545-550
pubmed: 29461463
Crit Care Med. 2018 Jun;46(6):e489-e495
pubmed: 29432347
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
J Crit Care. 2017 Dec;42:35-41
pubmed: 28672145
Stat Med. 1997 Jul 15;16(13):1529-42
pubmed: 9249923
J Intensive Care Med. 2018 Dec;33(12):687-694
pubmed: 28013574
J Crit Care. 2018 Apr;44:51-56
pubmed: 29065350
Turk J Pediatr. 2018;60(6):691-701
pubmed: 31365206
J Crit Care. 2020 Aug;58:118-124
pubmed: 31174974
Ann Med. 2021 Dec;53(1):2268-2277
pubmed: 34854770
Intensive Care Med. 2017 Mar;43(3):304-377
pubmed: 28101605
Ann Intensive Care. 2021 Aug 21;11(1):128
pubmed: 34417919
Am J Respir Crit Care Med. 2016 Feb 1;193(3):259-72
pubmed: 26414292

Auteurs

Kamran Shadvar (K)

Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Nader Nader-Djalal (N)

Department of Anesthesiology, Buffalo University, Buffalo, NY, USA.

Noushin Vahed (N)

Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Sarvin Sanaie (S)

Neurosciences Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.

Afshin Iranpour (A)

Al-Zahra Private Hospital, Dubai, UAE.

Ata Mahmoodpoor (A)

Evidence Based Research Center, General ICU, Shohada Hospital, Tabriz University of Medical Sciences, Gol Gasht Street, Tabriz, Iran. amahmoodpoor@yahoo.com.

Amir Vahedian-Azimi (A)

Trauma Research Center, Nursing Faculty, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Abbas Samim (A)

Chemical Injuries Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Farshid Rahimi-Bashar (F)

Anesthesia and Critical Care Department, Hamadan University of Medical Sciences, AyatolahMotahari BLVD, Resalat Square, Hamadan, 6514845411, Iran. fr_rahimibashar@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH